Howard E. Skipper is a scholar working on Molecular Biology, Oncology and Organic Chemistry.
According to data from OpenAlex, Howard E. Skipper has authored 88 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 17 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Howard E. Skipper's work include Biochemical and Molecular Research (13 papers), Cancer therapeutics and mechanisms (10 papers) and DNA and Nucleic Acid Chemistry (9 papers). Howard E. Skipper is often cited by papers focused on Biochemical and Molecular Research (13 papers), Cancer therapeutics and mechanisms (10 papers) and DNA and Nucleic Acid Chemistry (9 papers). Howard E. Skipper collaborates with scholars based in United States. Howard E. Skipper's co-authors include F. M. Schabel, Emil J. Freireich, E. A. Gehan, David P. Rall, L. H. Schmidt, W. S. Wilcox, S. Paul Perry, L. Lee Bennett, J. Thomson and R W Brockman and has published in prestigious journals such as Nature, JAMA and Journal of Biological Chemistry.
In The Last Decade
Howard E. Skipper
88 papers
receiving
3.1k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Countries citing papers authored by Howard E. Skipper
Since
Specialization
Citations
This map shows the geographic impact of Howard E. Skipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard E. Skipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard E. Skipper more than expected).
Fields of papers citing papers by Howard E. Skipper
This network shows the impact of papers produced by Howard E. Skipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard E. Skipper. The network helps show where Howard E. Skipper may publish in the future.
Co-authorship network of co-authors of Howard E. Skipper
This figure shows the co-authorship network connecting the top 25 collaborators of Howard E. Skipper.
A scholar is included among the top collaborators of Howard E. Skipper based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Howard E. Skipper. Howard E. Skipper is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Skipper, Howard E.. (1965). Summary of Informal Discussion on the Effects of Chemotherapy on the Kinetics of Leukemic Cell Behavior. Cancer Research. 25. 1553–1554.3 indexed citations
2.
Skipper, Howard E.. (1965). The effects of chemotherapy on the kinetics of leukemic cell behavior.. PubMed. 25(9). 1544–50.52 indexed citations
3.
Griswold, Daniel P., et al.. (1963). Experimental Evaluation of Potential Anticancer Agents: XII. Quantitative Drug Response of the SA180, CA755, and Leukemia L1210 Systems to a “Standard List” of “Active” and “Inactive” Agents. Cancer Research. 23. 271–519.10 indexed citations
4.
Skipper, Howard E.. (1961). The quality of the logic underlying present concepts on correlation in drug response between "animal cancer" and "human cancer." Or wouldn't it be better to look at the data?. PubMed. 21. 1100–2.1 indexed citations
5.
Laster, W R, et al.. (1961). Experimental evaluation of potential anticancer agents. IV. Host weight loss as it relates to false positives in drug evaluation.. PubMed. 21. 895–906.8 indexed citations
6.
Bennett, L. Lee, Howard E. Skipper, Linda Simpson, Glynn P. Wheeler, & W. S. Wilcox. (1960). Searches for exploitable biochemical differences between normal and cancer cells. V. Cellular conservation of purines.. PubMed. 20. 62–81.19 indexed citations
7.
Bennett, L. Lee, et al.. (1959). Searches for exploitable biochemical differences between normal and cancer cells. IV. Utilization of neucleosides and nucleotides.. PubMed. 19(2). 217–21.5 indexed citations
8.
Brockman, R W, et al.. (1959). A mechanism of resistance to 8-azaguanine. II. Studies with experimental neoplasms.. PubMed. 19. 856–69.40 indexed citations
Skipper, Howard E.. (1952). THE HAZARD INVOLVED IN THE USE OF CARBON-14. Nucleonics (U.S.) Ceased publication. 60(39). 1343–7.1 indexed citations
17.
Skipper, Howard E., et al.. (1952). The effect of folic acid on A-methopterin-induced inhibition of nucleic acid synthesis.. PubMed. 12(5). 369–70.7 indexed citations
Skipper, Howard E., Leonard L. Bennett, & L. W. Law. (1952). Effects of A-methopterin on formate incorporation into the nucleic acids of susceptible and resistant leukemic cells.. PubMed. 12(9). 677–9.23 indexed citations
20.
Skipper, Howard E., et al.. (1951). Carbamates in the chemotherapy of leukemia. VIII. Overall tracer studies on carbonyl-labeled urethan, methylene-labeled urethan, and methylene-labeled ethyl alcohol.. PubMed. 11(1). 46–51.45 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.